Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders approved Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion at the 2024-05-03 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-05-03
Exact text from the filing
Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,662,106 Against 72,899 Abstentions 6,064 Broker Non Votes 324,644
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders approved Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024 at the 2024-05-03 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-05-03
Exact text from the filing
Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024: For 3,012,801 Against 49,443 Abstentions 3,469
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders approved Elected Kevin L. Cornwell as a director of the Company at the 2024-05-03 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-03
Exact text from the filing
Elected Kevin L. Cornwell as a director of the Company: For 1,436,389 Withheld 1,304,680 Broker Non Votes 324,644 Elected Paul O. Richins as a director of the Company: For 907,483 Withheld 1,833,586 Broker Non Votes 324,644
View on SEC.gov